Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04163679 · ClinicalTrials.gov registry record · NA
Vaginal Preparation and Azithromycin to Reduce Post Cesarean Infections
A NA study, sponsored by Womack Army Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 84
- Enrollment target
NCT04163679: Clinical Trial NA study, sponsored by Womack Army Medical Center.
NCT04163679 is a NA study that was terminated before completion, run by Womack Army Medical Center. The registered enrollment target is 84 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04163679, a NA study, was terminated before completion, sponsored by Womack Army Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
Study Summary
asdgf
Primary Outcome
wound infection
Interventions
- PROCEDURE Vaginal Preparation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2019-09-18 |
| Est. Completion | 2021-07-30 |
| Phase | NA |
Why NCT04163679 stopped before completion
NCT04163679 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Vaginal Preparation is the first listed.
NCT04163679 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04163679 about?
NCT04163679 is a clinical study titled "Vaginal Preparation and Azithromycin to Reduce Post Cesarean Infections". asdgf
What is the current status of trial NCT04163679?
This trial is currently terminated. It is a NA study. The enrollment target is 84 participants. The study started on 2019-09-18. Estimated completion is 2021-07-30.
What interventions are being tested in trial NCT04163679?
The interventions under investigation include: Vaginal Preparation (PROCEDURE).
Who is sponsoring clinical trial NCT04163679?
This trial is sponsored by Womack Army Medical Center, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04163679's enrollment target sits among peer trials
84 983rd of 2000 higher than 1,011 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI